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Healthy public policy and its potential
Public policies, defined here as policies formulated at any 
level of government,1 have been key in bringing about some 
of the great public health achievements of the 19th and 20th 
centuries, including clean water and sanitation, immuniza-
tion, safe working conditions and fluoridation of water.2 
These examples represent “healthy public policies”, that is, 
public policies that have or are intended to have a positive 
impact on population health. Thus, public policies provide 
one of the primary means for a society to organize its efforts 
to protect and improve population health.3 It is increasingly 
recognized that public policy can also play a key role in 
the prevention and control of chronic, non-communicable 
diseases (NCDs). Indeed, the United Nations High-Level 
Meeting on Non-Communicable Diseases strongly empha-
sized the need for population-wide interventions involving 
education, legislation and regulatory and fiscal measures.4 
Public policy measures are likely to be as important in pro-
moting healthier diets and physical activity as they have been 
in reducing exposure to tobacco. However, the evidence on 
which public policies are effective in promoting healthier 
diets and physical activity is much scantier than the evidence 
surrounding tobacco control policies, some of which are 
known to be highly effective.5,6
Healthy public policy should be directed by evidence.7,8 
However, an evidence-based approach to formulating healthy 
public policy has proved difficult to develop and implement.9 
Evidence is required in three broad areas: policy content, 
policy implementation (i.e. translating content into effective 
policy) and policy outcomes (i.e. achievement of the desired 
effect).9 The aim of this paper is to present a framework de-
signed to facilitate the development and implementation of 
evidence-based healthy public policy for the prevention and 
control of NCDs. The framework, known as the “policy effec-
tiveness–feasibility loop” (PEFL), combines epidemiological 
modelling, local situation analysis and policy option appraisal 
and is designed to explicitly involve policy-makers. Below 
we describe the PEFL framework and its application within a 
project in four parts of the eastern Mediterranean.
Policy-making and research
In developing the PEFL framework, we were guided by the 
literature on the factors that influence public policy develop-
ment and on ways of encouraging the use of research evidence 
to formulate healthy public policy (Box 1). The framework 
highlights the importance of the “interface” between researchers 
and policy-makers, particularly of promoting personal contact 
and dialogue between them. Policy-makers need to receive 
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clear, persuasive information on disease 
burden and on interventions designed 
to mitigate the burden. Offering policy-
makers choice and flexibility, such as a se-
ries of policy options with different costs 
and benefits, is more likely to result in 
action than providing them with a single 
solution. It is important that the options 
reflect the political, social and economic 
realities within which a given policy will 
be implemented. Finally, ongoing policy 
surveillance and outcomes assessment 
should be conducted to guide future 
policy development and implementation.
The PEFL framework
The PEFL framework has three main 
components: epidemiological model-
ling, situation analysis and option ap-
praisal (Fig. 1). The epidemiological 
modelling and situation analysis com-
ponents are conducted simultaneously, 
and the results of both are then inte-
grated at the option appraisal stage. The 
framework is designed to foster dialogue 
and collaboration between researchers 
and policy-makers, especially during 
situation analysis and option appraisal. 
During the former, policy-makers act 
as participants who provide data and 
insights on a particular situation; in the 
latter, policy-makers play the key role, 
which consists of identifying the options 
that should be worked up in detail and 
subsequently implemented.
Each component of the PEFL 
framework is briefly described below. A 
critical description of its application in 
four parts of the eastern Mediterranean 
follows for illustrative purposes.
Epidemiological modelling 
In considering policy options for the 
prevention of chronic NCDs, a natural 
starting point is to try to understand 
their epidemiological distribution and, 
in particular, what drives trends in their 
incidence and mortality over time. The 
aim of the epidemiological modelling is 
to gain this understanding. The result-
ing model can then be used to explore 
the potential impact on incidence and 
mortality of different policy options 
intended to modify their determinants.
Our approach to epidemiological 
modelling is based on the coronary 
heart disease (CHD) IMPACT model, 
with the addition of a “new” diabetes 
policy model.13 The CHD IMPACT 
model, designed to estimate the relative 
contribution of changes in risk factors 
and treatment coverage to trends in 
mortality from CHD, has been suc-
cessfully used in several high- and 
middle-income countries.14–16 The 
model requires data on trends in CHD 
mortality, major risk factors (e.g. smok-
ing, arterial hypertension and diabetes) 
and coverage of effective treatments for 
the primary and secondary prevention 
of CHD (e.g. thrombolytic therapy for 
acute myocardial infarction and statins 
for hypercholesterolaemia). Identifying 
locally available data and assessing its 
quality are therefore important initial 
steps in the PEFL framework.
Situation analysis
The goal of the situation analysis is to 
identify policy gaps as well as oppor-
tunities for implementing new policies 
designed to improve health outcomes of 
interest. Our approach to the situation 
analysis has been developed over many 
years. At first it built on rapid appraisal 
methods17,18 that were later adapted 
and tested during the performance 
of situation analyses of governmental 
and health system responses to NCDs 
in Africa, particularly Cameroon and 
the United Republic of Tanzania.19 The 
approach was further developed as part 
of the project described in this paper.
The situation analysis is designed 
to investigate existing policy and its 
implementation at three levels (Fig. 2). 
Level 1, or document analysis, involves 
identifying, collating and systemati-
cally reviewing all relevant government 
materials on health policies and health 
services provision. Documents are identi-
fied with the help of policy-makers and 
other local stakeholders and are reviewed 
using standard proformas. This analysis 
is conducted to gain an understanding 
Box 1. Elements encouraging the use of research evidence in health policy, as addressed 
in the policy effectiveness–feasibility loop framework
•	Demonstrate	public	health	burden	and	benefit	or	harm	from	an	intervention9
•	Use	analytical	tools	and	prepare	and	communicate	data	effectively,	simply	and	persuasively.9 
Summarize with clear recommendations;8 personalized through a story9
•	 Promote	personal	contact	between	researchers	and	policy-makers7,9 e.g. through networks 
and “intermediary groups” (e.g. the media)10
•	 Invest	in	providing	accessible,	timely	and	relevant	research	for	policy-makers3,11,12
•	 Clear	political	leadership,	coordination	and	guidance7
•	 Estimate	intervention	cost9
•	 Consider	“interface	issues”	when	setting	priorities,	commissioning	research	and	communicating	
findings7
•	 Conduct	policy	surveillance	and	track	outcomes	with	different	types	of	evidence9
•	 Provide	policy-makers	with	costed	incremental	policy	options,	enabling	a	stepwise	approach	
to policy implementation9
Fig. 1. The policy effectiveness–feasibility loop
Trends in burden of disease and risk factors
Evaluation of 
interventions
Situation analysis:
stated and real policy,
health coverage, beliefs,
experience and opportunities
Option appraisal and selection: 
intervention development, 
feasibility, effectiveness and costs
Epidemiology modelling: to 
‘‘explain’’ incidence/mortality based 
on risk factor trends, treatment 
evidence, etc.
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of how the policy response is concep-
tualized (i.e. how it is meant to work in 
theory). In Level 2, key informants are 
interviewed to assess their awareness of 
and adherence to the theory and to obtain 
their insights into gaps and shortcom-
ings within the system. Key informants 
include policy-makers within ministries 
of health as well as other important stake-
holders. We developed semistructured 
interview schedules for these interviews. 
Finally, Level 3 involves investigating the 
extent to which the policies are influenc-
ing practice. In our work this has entailed 
direct participant observation (e.g. 
observing the delivery of care in health 
facilities) and individual interviews with 
patients and family members. Triangulat-
ing the data from the three levels provides 
a picture of policy as conceived theoreti-
cally versus actual practice and makes it 
possible to identify opportunities for 
implementing new policies and improv-
ing the implementation of existing ones.
Option appraisal and selection
Option appraisal and selection begins 
once the results of the epidemiological 
modelling and of the situation analysis 
have been obtained. The modelling 
identifies the major drivers of trends 
in disease incidence and mortality and 
enables “what if ” analyses to explore the 
impact of policies intended to reduce risk 
factor levels or increase the coverage of 
health-care interventions. The situation 
analysis provides insight into existing 
policy gaps and the feasibility and accept-
ability (political, social and economic) of 
different approaches to filling those gaps.
The results of the epidemiological 
modelling and situation analysis are 
used to generate a list of policy options. 
Items on the list are then prioritized 
with input from policy-makers and 
other stakeholders, and some of the 
options given higher priority are further 
investigated by the research team, who 
examine in detail their estimated costs, 
potential health benefits and cost–ef-
fectiveness ratios. The options worked 
up in this fashion are presented back to 
the policy-makers, who then choose the 
policies they wish to implement.
Using the PEFL framework 
The PEFL framework was developed as 
part of a multinational project known as 
MedCHAMPS (MEDiterranean studies 
of cardiovascular disease and hypergly-
caemia: analytical modelling of popula-
tions’ socioeconomic transition).20 The 
overall aim of the project was to inform 
policy for the prevention and control of 
cardiovascular diseases and diabetes in 
four parts of the eastern Mediterranean: 
the Syrian Arab Republic, Tunisia, Tur-
key and the West Bank and Gaza Strip.20 
The project, which began in 2009, was 
set up in a way intended to foster close 
collaboration between researchers and 
policy-makers. Its advisory commit-
tees, composed of policy-makers and 
researchers established within each 
study area at the start of the project, pro-
vided a forum for discussing the project’s 
progress and results as these became 
available. Seven senior policy-makers 
attended many meetings throughout the 
project. Although it would be premature 
to comment on the long-term success of 
the PEFL framework as applied in Med-
CHAMPS, which will not end until early 
2013, some conclusions can be drawn 
from the challenges faced and lessons 
learnt while implementing this approach.
Epidemiological modelling
The main modelling activity undertaken 
in MedCHAMPS was to build an IM-
PACT model in each of the four project 
areas to explain trends in CHD mortality 
over the past 10 to 15 years. The biggest 
challenge was finding the data needed 
to populate the epidemiological mod-
els. The first few months of the project 
were spent in identifying available data 
sources and appraising their quality and 
completeness. Among the sources iden-
tified and used were routine mortality 
statistics, national and local risk factor 
surveys and statistics on health facility 
activity and drug use. Nonetheless, a 
shortage of data remained a major chal-
lenge and this was accounted for in the 
model by making explicit assumptions 
based on expert opinion and conducting 
sensitivity analyses to test the effect of 
changing the assumptions. The results 
of the CHD modelling will be described 
in detail in another paper, but here it is 
worth noting that trends in age-adjusted 
CHD mortality differ between project 
areas. Mortality is increasing in Tunisia 
and the Syrian Arab Republic but is 
declining in Turkey and the West Bank 
and Gaza Strip. The modelling was able 
to show that these differences are partly 
due to different trends in the prevalence 
of smoking, mean blood pressure and 
mean blood cholesterol levels. Despite 
the shortage of data, however, the mod-
els were able to account for 75–100% of 
the trends in CHD mortality and from 
them it was possible to examine the 
likely impact of interventions on future 
epidemiological trends.
Because diabetes is a major, grow-
ing public health problem in the east-
ern Mediterranean, the need to model 
trends in diabetes rates was identified. A 
new diabetes model was built as part of 
MedCHAMPS.13 The model is designed 
to require minimum data while provid-
ing policy-makers with useful insights 
into the potential impact of different 
policy options on rates of diabetes and 
its complications.
Situation analysis
Fig. 2 illustrates the three levels involved 
in the situation analysis, as described 
earlier. The biggest obstacles to achiev-
ing this ambitious design were the 
relative novelty of and lack of familiarity 
with qualitative research on the health 
system in project areas. There were 
differences between areas. Qualitative 
health system research was most familiar 
in Turkey and the West Bank and Gaza 
Strip, where there is literature on the 
organization of the health sector, and 
it was least familiar in the Syrian Arab 
Republic, where no such literature exists 
and where critical scrutiny of a sector 
Fig. 2. Situation analysis: overview of methods
Conceptualization, 
awareness 
and commitment Potential interventions 
(locally appropriate and 
judged as feasible)
Gaps
Barriers
Opportunities
Policy document review;
key informant 
interviews (policy-makers 
and others)
Health-care worker and 
patient interviews; illness
narratives; focus group 
discussion and observation
Practice (including 
health practice 
and experience)
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of government activity was inherently 
problematic. These differences were im-
portant, moreover, because we needed 
to obtain ethical consent and official 
approval for similar timetables to gain 
access to clinics and key informants 
and perform the situation analyses in 
all four settings simultaneously. We 
were fortunate in that the standing of 
our research partners in each study area 
assured such access.
To examine “practice” we under-
took direct observations in four clinics 
in each study area. We purposively chose 
the clinics to reflect different socioeco-
nomic characteristics, both public and 
private facilities and a mix of urban and 
rural settings around the cities where 
project partners were based (Ramallah, 
Aleppo, Tunis and Izmir). At each clinic 
we conducted structured interviews 
with staff to investigate approaches and 
challenges in caring for patients with 
cardiovascular diseases and diabetes. 
We also interviewed patients and family 
members, also purposively chosen, to 
explore their health beliefs and treat-
ment experiences and identify any dif-
ferences by age, sex or socioeconomic 
status. The “practice” component of the 
situation analysis is not intended to be 
representative in an epidemiological 
sense, but rather, to complement and 
be triangulated with the information 
gained from document reviews and key 
informant interviews so as to highlight 
recurring issues, problems or dilemmas.
We fortunately completed data col-
lection for the situation analysis a few 
months before the events that marked 
the beginning of the “Arab awakening” 
in Tunisia in December 2010. Therefore, 
in two of the four project areas – the 
Syrian Arab Republic and Tunisia – our 
data reflect the situation that existed on 
the cusp of the events that have been 
unfolding since late 2010.
Option appraisal
As a starting point for the option ap-
praisal, recommended and potentially 
effective policy measures for the preven-
tion and control of diabetes and cardio-
vascular diseases were considered. Two 
frameworks were used for this purpose: 
stepwise policy options for NCD preven-
tion and control from the World Health 
Organization21 and the framework for 
public health interventions developed by 
the United Kingdom’s National Institute 
of Health and Clinical Excellence.22 In 
the workshops, policy-makers and re-
searchers considered the recommended 
options in light of the findings of the 
epidemiological modelling and situa-
tion analyses. The following questions 
were posed: (i) In light of the results of 
the epidemiological modelling, what 
interventions are particularly relevant 
given the known burden of disease and 
its determinants? (ii) In light of the 
results of the situation analyses, what 
interventions are likely to be acceptable 
and feasible? A list of potential policy 
options resulted from this exercise. To 
further prioritize the items on the list, 
policy-makers and other stakeholders 
were asked to score each potential policy 
option on a small set of criteria, includ-
ing feasibility and likely public health 
impact, in the same manner in which 
WHO prioritizes the research agenda 
for NCDs.23 All stakeholders complied 
with the request.
The prioritized options underwent 
further workup. This included cost 
estimates, cost-effectiveness ratios and 
a close look at their potential health 
benefits and implementation require-
ments, such as resources needed, roles 
and responsibilities involved and plans 
for monitoring and evaluation. Using this 
overall approach, five policy options were 
worked up in detail for each study area.
Discussion
This paper presents a pragmatic frame-
work for developing and prioritizing 
policy interventions tailored to local 
epidemiological, political and social 
conditions. The PEFL framework was 
developed as part of a multinational 
project aiming to inform policy for 
the prevention and control of cardio-
vascular diseases and diabetes in four 
middle-income territories. Central to 
the proposed approach is the iterative 
involvement of policy-makers in the 
collection of evidence and its appraisal.
The PEFL framework resembles the 
“equity effectiveness loop” proposed by 
Tugwell,24 which is intended to estimate 
the impact of interventions to reduce 
socioeconomic inequalities. The major 
difference is that our approach includes 
assessing the local context and the feasi-
bility of potential interventions. Further-
more, our focus is on policy-level inter-
ventions, and hence the situation analysis 
involves local policy-makers. The situa-
tion analysis and option appraisal stages 
of our framework are analogous to policy 
dialogue,25 as they facilitate discussion 
between stakeholders and researchers 
on policies and how to implement them. 
The outputs resulting from application 
of the framework can be used to prepare 
policy briefs26 for informing stakeholder 
discussions on policy options.
Studies have shown that evidence 
rarely leads to policy changes directly.10 
The relationship between evidence 
and policy implementation has been 
described as “complex, multifactorial, 
nonlinear and highly context-specific”.11 
Research evidence may be outweighed by 
other factors, such as political pressure 
from powerful interest groups. However, 
the adoption of evidence-based policy 
can be facilitated by involving policy-
makers in extended communication and 
interaction with researchers9 and by us-
ing conceptual frameworks such as the 
PEFL. Conceptual frameworks can also 
be useful in assessing research utilization 
and addressing the increasing demand 
for accountability in research expendi-
ture.8,27 Policy-makers and planners are 
often enthusiastic about decision-support 
frameworks, but these have seldom been 
used in practice. Some policy-makers 
may feel that frameworks oversimplify 
complex situations or may not under-
stand how frameworks operate work.12 
Frameworks should be easy to under-
stand and their assumptions should be 
explicit, particularly when planning and 
funding cycles are short and reorganiza-
tion is frequent.27 The PEFL framework 
is conceptually simple but does not over-
simplify the epidemiological modelling, 
situation analysis and option appraisal 
components. Our approach is consistent 
with the “interfaces and receptors” model 
proposed by Hanney et al.8 insofar as it 
aims to create interfaces between policy-
makers and researchers at various stages. 
Explicitly involving policy-makers in the 
epidemiological modelling stage is par-
ticularly valuable in promoting dialogue 
between researchers and policy-makers 
on what is currently known and where 
further data are required
As shown in  Box 2, one potential 
limitation of the PEFL framework is 
the methodological expertise required 
to conduct the epidemiological mod-
elling, the situation analysis and the 
option appraisal. The MedCHAMPS 
project has been building capacity in 
these three areas within the project 
areas. To facilitate the implementation 
of the PEFL framework in other set-
tings, researchers and policy-makers 
should jointly investigate the valid-
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ity and utility of ways of conducting 
epidemiological modelling, situation 
analysis and option appraisals that 
require fewer resources. In conclusion, 
our early results show that implement-
ing the PEFL framework within the 
MedCHAMPS project has success-
fully enabled researchers and policy-
makers to work together on identifying 
evidence-based, cost-effective and 
feasible policy options for NCD pre-
vention and control. ■
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摘要
使用证据支持健康的公共政策:政策的有效性-可行性循环
公共政策在改善人口的健康状况和控制疾病(包括非传染性
疾病)方面起着关键的作用。然而,采用以证据为基础制订的
健康公共政策的方法一直难以采用,这在一定程度上源于妨
碍研究人员和政策制定者之间的集成工作的障碍。本文介
绍了汇集流行病学建模、本地情况分析及选择方案评估以
促进研究人员和政策制定者之间合作的“政策有效性-可行
性循环”(PEFL)。流行病学建模探讨疾病发展趋势的决定
因素和改变这些因素的潜在健康益处。情况分析探讨了当
前政策的概念化、政策的认识水平、关键利益相关者之间
的承诺和实践中的实际结果,从而帮助查明政策差距。选择
方案评估结合流行病学建模和情况分析,研究各种政策选择
的方案可行性、成本和可能的健康益处。作者举例说明在
一个项目中如何使用PEFL,为地中海东部四个区域旨在预
防心血管疾病和糖尿病制定的公共政策提供信息。他们
的结论是,PEFL可能为研究人员和政策制定者提供成功合
作的有用框架,以制定基于证据的政策,他们还鼓励进一步
评估这种方法。
Box 2. Strengths and limitations of the policy effectiveness–feasibility loop (PEFL) 
framework
Strengths
•	Draws	on	previous	frameworks,	providing	comprehensive	consideration	of	socio-political	and	
economic context
•	Explicitly	incorporates	policy-makers’	views
•	Includes	economic	feasibility	assessment
•	Applies	to	a	variety	of	settings
•	Incorporates	sensitivity	analysis,	highlighting	elements	of	the	framework	where	uncertainty	
exists
•	Allows	policy-makers	and	implementers	to	draw	their	own	conclusions	and	actions	from	results
Limitations
•	Need	for	further	examples	of	practical	application
•	As	with	other	frameworks,	not	all	data	readily	available	for	input
•	 Involving	policy-makers	throughout	may	bias	research	used
•	High	degree	of	coordination	and	communication	needed,	with	possible	resource	implications
•	 Expertise	required	to	estimate	costs,	perform	epidemiological	modelling	and	provide	contextual	
information
صخلم
ىودلجا – ةسايسلا ةيلاعف ةقلح :ةيحصلا ةيمومعلا تاسايسلا معدل تاّنيبلا مادختسا
 فيو ناكسلا ةحص ينستح في ًايسيئر ًارود ةيمومعلا ةسايسلا بعلت
 ناك ،كلذ عمو .ةيدعلما يرغ ضارملأا اهيف ماب ،ضارملأا ةحفاكم
 تاسايس عضول ةيمارلا تاّنيبلا لىع دنتسم جنه ذيفنت بعصلا نم
 لمعلا قيعت يتلا زجاولحا لىإ ًايئزج ىزعي ام وهو ،ةيحص ةيمومع
 ةقرولا  هذه  فصتو  .ةسايسلا  عانصو  ينثحابلا  ينب  لماكتلما
 ديحوتب  موقت  يتلا  )PEFL(  “ىودلجا–ةسايسلا  ةيلاعف  ةقلح”
 ةيغب  تارايلخا  مييقتو  ةيلحلما  عاضولأا  ليلتحو  ةيئابولا  ةجذمنلا
 ةجذمنلا فشكتستو .ةسايسلا عانصو ينثحابلا ينب نواعتلا معد
 ةلمتحلما  ةيحصلا  دئاوفلاو  ضرلما  في  تاهاتجلاا  تاددمح  ةيئابولا
 تاسايسلل ليالحا ميمصتلا عاضولأا ليلتح ىرحتيو .اهليدعت نم
 باحصأ  ينب  سيايسلا  ديعصلا  لىع  مازتللااو  يعولا  ىوتسمو
 في دعاسيس امم ،ةسرمالما دنع لعفلاب ثديح امو ينيسيئرلا ةحلصلما
 ينب لماكتلا لىإ تارايلخا مييقت يدؤيو .ةيسايسلا تارغثلا ديدتح
 فيلاكتلاو ىودلجا يرتح ةيغب عاضولأا ليلتحو ةيئابولا ةجذمنلا
 حضويو  .ةيسايسلا  تارايلخا  ىتشل  ةلمتحلما  ةيحصلا  دئاوفلاو
 في  “ىودلجا–ةسايسلا  ةيلاعف  ةقلح”  مادختسا  مت  فيك  نوفلؤلما
 ةيبلقلا ضارملأا يقوتل ةيمومعلا تاسايسلا غلابلإ عيراشلما دحأ
 اوصلخو .طسوتلما قشر في قطانم عبرأ في يركسلا ءادو ةيئاعولا
 ًاراطإ  مدقت  نأ  نكمي  “ىودلجا–ةسايسلا  ةيلاعف  ةقلح”  نأ  لىإ
 ةسايس عضو ةيغب نواعتلا حاجنلإ ةسايسلا عانصو ينثحابلل ًاديفم
 اذله  مييقتلا  نم  ديزلما  ءارجإ  نوعجشي  مهو  تاّنيبلا  لىع  ةدنتسم
.جهنلا
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Résumé
Utilisation de preuves à l’appui d’une politique publique saine: la boucle entre efficacité et faisabilité d’une politique
La	politique	publique	joue	un	rôle	clé	dans	l’amélioration	de	la	santé	
de la population et dans la lutte contre les maladies, notamment les 
maladies	non	 transmissibles.	 Il	 a	 cependant	été	difficile	de	mettre	
en	œuvre	 une	 approche	 fondée	 sur	 des	 preuves	pour	 formuler	
une	politique	publique	saine,	en	partie	en	 raison	des	barrières	qui	
entravent	 le	 travail	 intégré	entre	chercheurs	et	décideurs.	Cet	article	
décrit	une	«boucle	entre	efficacité	et	faisabilité	d’une	politique»	(PEFL)	
réunissant	 la	modélisation	épidémiologique,	 l’analyse	de	 la	situation	
locale	et	l’évaluation	des	options	afin	de	favoriser	la	collaboration	entre	
chercheurs	et	décideurs.	La	modélisation	épidémiologique	explore	les	
déterminants	des	évolutions	de	maladie	et	 les	avantages	 sanitaires	
potentiels	résultant	de	leur	modification.	L’analyse	de	situation	étudie	
la	conceptualisation	actuelle	de	la	politique,	le	niveau	de	conscience	
politique	et	 l’engagement	des	principaux	 intervenants,	et	ce	qui	 se	
passe	réellement	dans	la	pratique,	aidant	ainsi	à	identifier	les	lacunes	
de	 la	 politique.	 L’évaluation	des	 options	 intègre	 la	modélisation	
épidémiologique	et	l’analyse	de	situation	pour	étudier	la	faisabilité,	les	
coûts	et	les	avantages	sanitaires	potentiels	de	diverses	options	politiques.	
Les	auteurs	montrent	comment	la	PEFL	a	été	utilisée	dans	un	projet	
visant	à	éclairer	 la	politique	publique	sur	 la	prévention	des	maladies	
cardiovasculaires	et	du	diabète	dans	quatre	régions	de	la	Méditerranée	
orientale.	Ils	concluent	que	la	PEFL	peut	offrir	un	cadre	utile,	permettant	
aux	chercheurs	et	aux	décideurs	de	réussir	à	travailler	ensemble	pour	
créer	une	politique	basée	 sur	des	preuves,	et	 ils	 encouragent	une	
évaluation	plus	approfondie	de	cette	approche.
Резюме
Использование доказательств в поддержку здоровой государственной политики: цикл эффективности-
осуществимости политики
Общественная политика играет ключевую роль в улучшении 
здоровья населения и регулировании заболеваний, включая 
неинфекционные заболевания. Тем не менее, реализация 
доказательного подхода к формулированию здоровой 
государственной политики представляется затруднительной, 
отчасти из-за барьеров, препятствующих совместной работе 
исследователей и представителей политических структур. В этом 
докладе описывается «цикл эффективности-осуществимости 
политики» (ЦЭОП), объединяющий эпидемиологическое 
моделирование, локальный ситуационный анализ и вариантную 
оценку для активизации совместной работы исследователей и 
представителей политических структур. Эпидемиологическое 
моделирование исследует определяющие факторы тенденций 
заболевания, а также потенциальную пользу для здоровья 
от их преобразования. Ситуационный анализ изучает 
текущее концептуальное представление политики, уровень 
информированности и приверженность политике ключевых 
заинтересованных сторон, а также то, что в действительности 
происходит на практике, таким образом, содействуя выявлению 
недостатков политики. Вариантная оценка объединяет 
эпидемиологическое моделирование и ситуационный анализ для 
исследования обоснованности, затрат и вероятной пользы для 
здоровья различных вариантов политики. Авторы иллюстрируют, 
как ЦЭОП использовался в проекте по информированию 
государственных служб о предотвращении сердечно-сосудистых 
заболеваний и сахарного диабета в четырех регионах восточного 
Средиземноморья. Они делают вывод, что ЦЭОП может стать 
эффективной основой для ведения успешной совместной 
работы исследователей и представителей политических структур 
для выработки политики, основанной на доказательствах, и 
призывают к дальнейшей оценке этого подхода.
Resumen
El uso de datos probatorios para reforzar la política sanitaria pública: una política de circuito cerrado eficacia-viabilidad 
Las políticas públicas desempeñan un papel fundamental en la mejora 
de la salud de la población y el control de enfermedades, incluidas las 
enfermedades no transmisibles. Sin embargo, ha sido difícil implementar 
un	enfoque	basado	en	datos	probatorios	para	 formular	una	política	
sanitaria	pública,	debido	en	parte	a	los	obstáculos	que	impiden	el	trabajo	
integrado entre investigadores y legisladores. El presente documento 
describe una política de circuito cerrado eficacia-viabilidad (PEFL, 
por	sus	siglas	en	 inglés)	que	 reúne	 la	modelización	epidemiológica,	
el análisis de la situación local y la valoración de las opciones para 
promover la colaboración entre investigadores y legisladores. El modelo 
epidemiológico examina los factores determinantes de las tendencias 
de una enfermedad y los beneficios sanitarios posibles resultantes de 
una modificación de los mismos. El análisis de la situación investiga 
la conceptualización actual de la política, el nivel de conciencia y 
compromiso	con	esa	política	entre	las	partes	clave	interesadas	y	lo	que	
sucede en la práctica, ayudando, por tanto, a identificar las lagunas en la 
política. La valoración de las opciones integra el modelo epidemiológico 
y el análisis de la situación para averiguar la viabilidad, los costes 
y los beneficios sanitarios posibles de varias políticas posibles. Los 
autores ilustran cómo se empleó el PEFL en un proyecto para informar 
acerca de una política pública para la prevención de enfermedades 
cardiovasculares y diabetes en cuatro áreas del Mediterráneo Oriental. 
Concluyen	que	el	PEFL	puede	ofrecer	un	marco	útil	a	los	investigadores	
y	legisladores	para	trabajar	con	éxito	juntos	con	objeto	de	crear	una	
política basada en datos probatorios, y animan a seguir evaluando 
dicho	enfoque.
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